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Introduction: Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower
extremities. It affects about 0.3–1.2% of diabetic patients, the majority of whom have type 1 diabetes. The etiology and
pathogenesis of this disorder are still unclear. NL is characterized by skin rash that usually affects the shins. The average
onset is 30 years, with females being affected more commonly. There are very few reported cases of necrobiosis
lipoidica in children. Case report: We report a case of a 16 year old girl affected by type 1 diabetes mellitus (15 years
disease duration) who developed an erythematous nodular rash on the lower extremities and interscapular area. In the
suspect of necrobiosis lipoidica, a skin biopsy was performed (lower extremities and interscapular area). The
microscopic evaluation of the pretibial lesions was suggestive of necrobiosis lipoidica. The smaller lesions in the
interscapular area showed signs of perivascular dermatitis which could be consistent with early stages of necrobiosis
lipoidica. Local treatment with tacrolimus determined a progressive improvement of the lesions. Conclusion: In patients
with T1DM, diagnosis of NL of the lower legs is usually unequivocal. However, diagnosis may be more challenging in
the presence of lesions with recent onset and/or atypical clinical presentation and unusual site. In these cases, NL must
always be taken in consideration in order to avoid misdiagnosis, wrong/late treatment decisions, and progression to
ulceration.
Introduction
Necrobiosis lipoidica (NL) is a rare chronic granulomatous
dermatitis first described in 1929 by Oppenheim that usually
appears in the lower extremities that affects about 0.3–1.2% of
diabetic patients, the majority of whom have type 1 diabetes.1
The etiology and pathogenesis of this disorder are still unclear.
NL is characterized by a skin rash that usually affects the shins.
The average onset is 30 y, with females being affected more com-
monly. There are very few reported cases of necrobiosis lipoidica
in children. We report a case of a 16 y old girl who developed
lesions on the lower extremities and in the interscapular area,
which is an unusual location.
Case report
The patient, a Caucasian 16-y-old girl, was born at term by
non-consanguineous, healthy parents. Type 1 diabetes (T1DM)
had been diagnosed at one year of age. Our patient’s medical his-
tory was otherwise unremarkable. Until the age of 12 she main-
tained an adequate glucose control with HbA1c < 34 mmol/
mol. Thereafter her glucose control progressively worsened with
a HbA1c of 86 mmol/mol. At the age of 16, during a routine
diabetes follow-up visit, the patient presented with erythematous
subcutaneous nodular lesions which had appeared 4 mo earlier,
initially in the pretibial area and subsequently in the interscapular
area. Her HbA1c was 64 mmol/mol and daily insulin require-
ments were 0.95 U/kg/day. In the suspect of necrobiosis lipoid-
ica, a skin biopsy was performed (lower extremities and
interscapular area) (Figs. 1 and 2). The microscopic evaluation
of the pretibial lesions was suggestive of necrobiosis lipoidica.
The smaller lesions in the interscapular area showed signs of peri-
vascular dermatitis which could be consistent with early stages of
necrobiosis lipoidica (Fig. 3). Local treatment with tacrolimus
determined a progressive improvement of the lesions. Diabetes
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self-management education
was reinforced and her
HbA1c showed a gradual
reduction.
Discussion
NL in the pediatric popu-
lation has been described in
2.3% of cases.2 It usually
consists of a rash involving
the lower extremities. It may
initially be represented by
erythematous circular pap-
ules which may gradually
progress to yellowish-brown,
telangectatic plaques with
central atrophy and raised
violaceous border. It rarely
involves hands, fingers, face
and scalp.3 The etiology of
NL is still currently elusive
and few data exist regarding
the pediatric population.
However, due to the signifi-
cant relationship with diabe-
tes (75–90% of patients
with NL have or will
develop T1DM), many
studies have proposed
microangiopathy as leading
etiological suspect.
Immune-complex vasculitis
and collagen abnormalities
may also represent potential
underlying causes.4 Previous
studies have shown that glu-
cose control does not appear
to be correlated with NL
onset and severity. How-
ever, a study by Cohen con-
cluded on the contrary, that
NL is usually associated
with poor glucose control
and that a tighter glucose
control, as currently prac-
ticed, might improve or pre-
vent this disorder.5
Diagnosis of NL is
mainly clinical, but a bio-
ptic evaluation may be use-
ful especially in the early
stages of disease. Differen-
tial diagnosis include
erythema nodosum, lupus
Figure 1. Erythematous and subcutaneous nodular lesions at the lower limbs.
Figure 2. Erythematous and subcutaneous nodular lesions at the intrascapular region.
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panniculitis, granuloma annulare, sarcoido-
sis and amyloidosis.
Microscopic evaluation usually shows
degeneration of collagen, granulo-
matous inflammation of subcutaneous tis-
sues and of blood vessels, capillary
basement membrane thickening and oblit-
eration of vessel lumen. Spontaneous remis-
sion of NL may present in less than 20% of
cases. Ulceration is the most frequent com-
plication and appears in 25–33% of cases.
Rarely, squamous cell carcinoma may
develop in areas of NL.6 Several therapeutic
options for NL can be proposed. However
its treatment still remains a challenge. Initial
therapy includes topical, intralesional or
systemic corticosteroids. Some authors have
reported a beneficial effect from smoking
cessation and blood glucose control. Other
therapeutic options are antiplatelet agents,
cyclosporine, thalidomide, clofazimine,
anti-TNF agents, fumaric acid esters,
PUVA, photodynamic therapy, hydroxy-
chloroquine, and tacrolimus.7-13
Conclusions
In patients with T1DM, diagnosis of NL of the lower legs
is usually unequivocal. However, diagnosis may be more chal-
lenging in the presence of lesions with recent onset and/or
atypical clinical presentation and unusual site. In these cases,
NL must always be taken in consideration in order to avoid
misdiagnosis, wrong/late treatment decisions and progression
to ulceration.
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Figure 3. Focal collagen necrosis with surrounding histiocytes that palisade in a radial pattern.
Mononuclear and plasmacellular interstitial inﬁltrate.
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